Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CNTA | Share Option (right to buy) | Award | $0 | +59K | $0.00 | 59K | Jan 29, 2021 | Ordinary Shares | 59K | $4.11 | Direct | F1, F2, F3, F4, F5 | |
transaction | CNTA | Share Option (right to buy) | Award | $0 | +9.49K | $0.00 | 9.49K | Jan 29, 2021 | Ordinary Shares | 9.49K | $4.87 | Direct | F1, F2, F4, F5, F6 | |
transaction | CNTA | Share Option (right to buy) | Award | $0 | +208K | $0.00 | 208K | Feb 19, 2021 | Ordinary Shares | 208K | $5.84 | Direct | F1, F2, F4, F5, F7 | |
transaction | CNTA | Share Option (right to buy) | Award | $0 | +138K | $0.00 | 138K | May 27, 2021 | Ordinary Shares | 138K | $20.00 | Direct | F4, F5, F8 |
Id | Content |
---|---|
F1 | On May 20, 2021, the Issuer effected a share capital reorganization, which had the effect of a one for two reverse share split of the Issuer's share capital ("Stock Split"). This amount has been adjusted to give effect to the Stock Split. |
F2 | This transaction occurred prior to the effectiveness of the Issuer's registration under Section 12 of the Securities Exchange Act of 1934 and is being reported on Form 4 solely for purposes of compliance with Rule 16a-2(a) under the Securities Exchange Act of 1934, as amended. The securities covered by such transaction were previously included on the Reporting Person's Form 3. |
F3 | 56.25% of the shares subject to such option are vested as of January 29, 2021. The remaining 43.75% of the shares subject to such option shall vest and become exercisable monthly beginning on February 1, 2021. |
F4 | Represents A Ordinary Shares that will be redesignated as Ordinary Shares immediately prior to the closing of the initial public offering. |
F5 | The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. |
F6 | 25% of the shares subject to such option are vested as of January 29, 2021. The remaining 75% of the shares subject to such option shall vest and become exercisable monthly beginning on February 1, 2021. |
F7 | 25% of the shares subject to such option shall vest and become exercisable on February 19, 2022 and the remaining 75% of the shares subject to such option shall vest and become exercisable in 36 monthly installments on the first day of each month thereafter. |
F8 | 25% of the shares subject to such option shall vest and become exercisable on February 1, 2022 and the remaining 75% of the shares subject to such option shall vest and become exercisable in 36 monthly installments on the first day of each month thereafter. |